Orange Book product · Generic (ANDA)
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
At a glance
Aug 04, 2021
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 04, 2021
4 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Strength
EQ 4MG PHOSPHATE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215654
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DEXAMETHASONE SODIUM PHOSPHATE
- —DEXACORTBrand (NDA)
NDA 013413 · UCB INC
- —DEXACORTBrand (NDA)
NDA 014242 · UCB INC
- —DECADRONBrand (NDA)
NDA 011983 · MERCK
- —DECADRONBrand (NDA)
NDA 012071 · MERCK
- —HEXADROLBrand (NDA)
NDA 014694 · ASPEN GLOBAL INC
- —DECADRONBrand (NDA)
NDA 011977 · MERCK
- —DECADRONBrand (NDA)
NDA 011984 · MERCK
- 2024DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 217797 · MICRO LABS
- 2023DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 211451 · HIKMA
- 2023DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 214890 · GENEYORK PHARMS
- 2020DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 210966 · EUGIA PHARMA
- 2019DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 210967 · EUGIA PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
